Covered recipient · General Payments record
DOUGLAS WHITE
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2025
$383.26
- Reported across 18 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $383.26 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $227.98 | 12 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.73 | 1 |
| Organon LLC | $39.75 | 2 |
| GENZYME CORPORATION | $30.04 | 1 |
| ABBVIE INC. | $25.13 | 1 |
| GlaxoSmithKline, LLC. | $19.63 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $383.26 | 18 |
Payment records · PY2025 (18)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.13 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204736462 | CMS |
| Amgen Inc. | $21.07 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396348 | CMS |
| Amgen Inc. | $21.42 | 05/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396360 | CMS |
| Amgen Inc. | $24.53 | 06/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396344 | CMS |
| Amgen Inc. | $16.85 | 07/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396358 | CMS |
| Amgen Inc. | $20.24 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396350 | CMS |
| Amgen Inc. | $5.62 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227113084 | CMS |
| Amgen Inc. | $29.65 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396354 | CMS |
| Amgen Inc. | $22.81 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396356 | CMS |
| Amgen Inc. | $33.70 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396352 | CMS |
| Amgen Inc. | $3.45 | 11/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227113082 | CMS |
| Amgen Inc. | $25.46 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228396346 | CMS |
| Amgen Inc. | $3.18 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227113086 | CMS |
| GENZYME CORPORATION | $30.04 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233598391 | CMS |
| GlaxoSmithKline, LLC. | $19.63 | 02/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190361336 | CMS |
| Novartis Pharmaceuticals Corporation | $40.73 | 05/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200592672 | CMS |
| Organon LLC | $16.62 | 02/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237692680 | CMS |
| Organon LLC | $23.13 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1237692682 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.